Tue, Oct 6, 3:05 PM, Zacks
Boston Scientific's Bioabsorbable Stent Wins FDA Approval
According to Boston Scientific (BSX), this launch will be a significant milestone in the history of stent technology evolution.
Thu, Oct 1, 12:35 PM, Zacks
Boston Scientific Captivator EMR to Treat Esophageal Cancer
The launch reflects Boston Scientific's (BSX) attempts to bolster its footprint in the global multi-billion dollar endoscopic devices market.